Welcome to the Pubget Medical Subject Headings (MeSH) browser.
Click on a topic or subtopic below to explore related papers. You'll find the most recent paper about the current MeSH term along with other related papers below.
Peptides (33)
- Antimicrobial Cationic Peptides
- Aptamers, Peptide
- Charybdotoxin
- Cholecystokinin
- Diazepam Binding Inhibitor
- Disintegrins
- Distamycins
- Edeine
- Fibrinopeptide A
- Fibrinopeptide B
- Glycopeptides
- Intercellular Signaling Peptides and Proteins
- Intracellular Signaling Peptides and Proteins
- Lipopeptides
- Myocardial Depressant Factor
- Neuropeptides
- Oligopeptides
Articles on Peptides
-
An update on hereditary angioedema.
Curr Opin Pediatr 24(5):638-46 (2012) PMID 22935756
To review and update the management and understanding of hereditary angioedema (HAE), while integrating insights into pediatric subtleties that exist in practice. Major advances have recently been made in HAE treatment. Ecallantide (a kallikrein inhibitor approved for... -
Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results
J Med Econ 15(s2):1-5 (2012) PMID 22853443
The purpose of this study was to investigate the preferences of people with diabetes for liraglutide vs other glucose lowering drugs, based on outcomes of clinical trials. Willingness to pay (WTP) for diabetes drug treatment was assessed by combining results from a re... -
Abstracts of the 32nd European Peptide Symposium. September 2-7, 2012. Athens, Greece.
J Pept Sci (2012) PMID 23025006
-
Hereditary angioedema treatment options: the availability of new therapies.
Ann Med 44(6):523-9 (2012) PMID 22784006
Hereditary angioedema (HAE) is a potentially life-threatening autosomal dominant disease characterized by recurrent episodes of oedema, commonly occurring in the skin, abdomen, and upper respiratory tract. After many years during which limited treatment options were available, a rang... -
Chimeric glutathione S-transferases containing inserts of kininogen peptides: potential novel protein therapeutics.
J Biol Chem 287(26):22142-50 (2012) PMID 22577144
We report here the design, expression, and functional analysis of eight engineered GST proteins (denoted GSHKTs) in which peptides ranging in size from 8 to 16 amino acids and derived from human high molecular weight kininogen (HK) domain 5 were inserted into GST (between Gly-49 and Leu-50). Peptide... -
Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden.
Lancet Oncol 13(6):642-8 (2012) PMID 22503213
We investigated whether polyQ diseases reduce the risk of cancer development. Data on patients with the polyQ diseases Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), and hereditary ataxia (HA) in Sweden were linked to the Swedish Cancer Registry. We calculated standa... -
PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
FEBS J 279(11):1929-42 (2012) PMID 22429328
These results demonstrate that PEP-1-HSP27 provides a potential strategy for therapeutic delivery against various diseases and is a potential tool for the treatment of PD. © 2012 The Authors Journal compilation © 2012 FEBS.... -
Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obe...
Eur J Clin Nutr 66(5):606-12 (2012) PMID 22190134
I collagen (P<0.001) persisted following weight regain, independent of exercise. The results of the present study, which is the first to examine changes in bone mass and turnover during carefully controlled weight regain, suggest that weight-loss-induced perturbations in bone mass an... -
Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obe...
Eur J Clin Nutr 66(5):606-12 (2012) PMID 22190134
I collagen (P<0.001) persisted following weight regain, independent of exercise. The results of the present study, which is the first to examine changes in bone mass and turnover during carefully controlled weight regain, suggest that weight-loss-induced perturbations in bone mass an... -
Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents
Diabetes Metab (2012) PMID 22405266
The two classes of incretin-related therapies, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have become important treatment options for patients with type 2 diabetes. Sitagliptin, saxagliptin, vildagliptin and linagliptin, the a...
